Sex Differences in Outcomes of Chimeric Antigen Receptor (<scp>CAR</scp>) T‐Cell TherapyJia Yi Tan, Talal Hilal, Daniel Ezekwudo et al.|Cancer Medicine|2025Cited by 6
Real-world comparison of CAR T-cell therapy versus bispecific antibodies in relapsed or refractory multiple myelomaJia Yi Tan, Talal Hilal, Daniel E. O’Leary et al.|Blood|2025Cited by 0